Aquestive Therapeutics, Inc. Common Stock (AQST) News

Latest headlines that mention AQST, newest first · each headline opens the original publisher

AQST quote

Last price: $3.97
Day change: -0.75%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

AQST headlines

last 30 days

Investing.com 10d ago

Aquestive Therapeutics CEO sells $105,600 in shares

General T3AQST

Seeking Alpha News 10d ago

Aquestive: FDA Acceptance Of Anaphylm Resubmission Makes For Rating Upgrade

General T2AQST

Seeking Alpha 12d ago

Aquestive announces FDA review of Anaphylm sublingual film

General T2AQST

Seeking Alpha 13d ago

Aquestive rises on licensing deal with Eton for antiseizure therapy

General T2AQST

Seeking Alpha News 26d ago

Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success

General T2AQST

AQST news alerts

Get an alert by email or push when a new headline mentions AQST.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.